7AS-17103-08244
2 vaccinations
2 coded responses
21 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 441 / OH
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-08
Registered in v-safe
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
-
2021-03-25
Dose 2 — Pfizer-BioNTech
- 2021-03-25
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Night sweats — Feeling: Fair · Site: Pain · Fever · Muscle or body achesFree text: Night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-06-24
- 2021-09-23
-
2022-03-25
Survey response — 12 months, dose 2MedDRA: Gastroenteritis viral — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stomach fluMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Night sweats
Release 11 — 12 months, dose 2
Symptoms: Stomach flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis viral | · | · | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release